Published 28 August 2008, doi:10.1136/bmj.a1110
Cite this as: BMJ 2008;337:a1110

Clinical Review

Managing drug resistant tuberculosis

¹ Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London WC1E 6JB, ² Clinical Research Unit, London School of Hygiene & Tropical Medicine, London WC1E 7HT, ³ Centre for Molecular Microbiology and Infection, Imperial College, London SW7 2AZ

doi: 10.1136/bmj.a1184

The first 150 words of the full text of this article appear below.

Drug resistant tuberculosis is becoming more common Traditional laboratory methods for detecting drug resistance are slow and not generally available outside specialist laboratories. Rapid molecular methods are increasingly used in well resourced settings, and simple, cheap alternatives are being developed for resource limited settings The evidence base to guide drug treatment of resistant tuberculosis is weak, and randomised controlled trials are needed A service advising on the management of multidrug resistant tuberculosis is available in the United Kingdom Priorities for prevention of drug resistant tuberculosis include prompt detection of cases, effective treatment of drug sensitive and drug resistant cases, and prevention of tuberculosis transmission

Antituberculosis drug resistance is increasing both in the United Kingdom and internationally.^{1 2} It has come to greater public attention with the emergence of extensively drug resistant tuberculosis (box 1) in South Africa, where an outbreak proved rapidly fatal among people with advanced HIV infection.³ In this . . . [Full text of this article]

Global risk factors
Additional risk factors in United Kingdom

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Extensive transmission of Mycobacterium tuberculosis from 9 year old child with pulmonary tuberculosis and negative sputum smear

S Paranjothy, M Eisenhut, M Lilley, S Bracebridge, I Abubakar, R Mulla, K Lack, D Chalkley, J Howard, S Thomas, and M McEvoy
BMJ 2008 337: a1184. [Extract] [Full Text]

Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data

Michelle E Kruijshaar, John M Watson, Francis Drobniewski, Charlotte Anderson, Timothy J Brown, John G Magee, E Grace Smith, Alistair Story, and Ibrahim Abubakar
BMJ 2008 336: 1231-1234. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Sanatorium by any other name

Bernard A Foëx
bmj.com, 8 Sep 2008 [Full text]

MDR-TB Public Health Importance

Vivek A Furtado
bmj.com, 10 Sep 2008 [Full text]

Risk factors for MDR TB

John P Watson
bmj.com, 7 Oct 2008 [Full text]

Online poll

Find out more on doc2doc >>